Investors

Northzone is a venture capital firm with office spanning Europe and North America, looking to invest and guide innovative technology companies.

Norwest Venture Partners invest in early-stage venture projects with world-class technologies and entrepreneurs; later-stage companies with existing customers, strong sales and top tier management and co-investors.

We bring together the very best industry experts, super relevant strategic partners and our unique perspective on B2B SaaS to create a multiplying effect for our portfolio. We accelerate our portfolio with a post-investment 100 day plan with dedicated operational resource. We fast track introductions to partners, experts and our portfolio and provide an ongoing programme of value-add engagement.

NSI Ventures makes investments in early-stage technology companies based in Southeast Asia.

Nyca Partners is a US-based venture capital firm which exclusively invests in early stage financial technology companies across North America as well as the Middle East & Israel.

In 2016 the firm announced a second fund of $125m to go with the firms initial fund of $30m in 2014.

Oak HC/FT invests in Healthcare Information & Services (HC) and Financial Services Technology (FT) in the United States. In 2017 the firm secured $600m for their second fund.

Obvious Ventures invests in US startup companies looking to deliver a positive social and environmental impact on the world.

We’re one of Europe’s largest venture capital teams, and the most entrepreneur-friendly.

Omega Pharma specialises in delivering innovative over-the-counter (OTC) treatments that can be purchased without a prescription.The company is committed to making a difference by helping people lead healthier lives and increasing their sense of well-being.

Omni Partners is focused on providing investors access to products that consistently deliver absolute returns. In order to achieve this objective, the firm combines demonstrated trading expertise with a strong emphasis on the proactive management of risk.